uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för kvinnors och barns hälsa, Pediatrik.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för immunologi, genetik och patologi, Experimentell och klinisk onkologi.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för immunologi, genetik och patologi, Experimentell och klinisk onkologi.
Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.
Vise andre og tillknytning
2016 (engelsk)Inngår i: European Journal of Haematology, ISSN 0902-4441, E-ISSN 1600-0609, Vol. 97, nr 5, s. 430-438Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

OBJECTIVES: To study Hodgkin lymphoma (HL) microenvironment in a Swedish paediatric population and its relation to clinical parameters.

METHODS: Tumour tissue from classical HL (cHL) (n=87) and nodular lymphocyte predominant HL (NLPHL) (n=11) was investigated for Epstein-Barr Virus (EBV) and analysed for eosinophils, mast cells and macrophages.

RESULTS: In cHL, EBV positivity was more common in low age (p<0.001) and in mixed cellularity (MC) (p<0.001). Higher mast cell infiltration was seen in stage III-IV (p<0.001), and with presence of B-symptoms (p=0.01). Cases with high mast cell counts displayed higher erythrocyte sedimentation rate (ESR), lower haemoglobin and albumin levels. Higher macrophage infiltration was seen in stage III-IV (p=0.02) and there was elevated ESR and neutrophil count. All NLPHL cases were EBV negative, had lower rates of inflammatory cells and lower degree of inflammatory reaction in laboratory parameters. There was no difference in survival estimates with regard to infiltration of inflammatory cells.

CONCLUSIONS: Higher levels of mast cells and macrophages in cHL tumours reflected the clinical presentation in laboratory parameters, B-symptoms and more advanced stages. NLPHL differs from cHL in numbers of inflammatory cells in the tumour, and in laboratory parameters. This article is protected by copyright. All rights reserved.

sted, utgiver, år, opplag, sider
2016. Vol. 97, nr 5, s. 430-438
Emneord [en]
paediatric, Hodgkin, Microenvironment, mast cells, eosinophils, macrophages
HSV kategori
Forskningsprogram
Patologi
Identifikatorer
URN: urn:nbn:se:uu:diva-278917DOI: 10.1111/ejh.12747ISI: 000388630800003PubMedID: 26872637OAI: oai:DiVA.org:uu-278917DiVA, id: diva2:907176
Forskningsfinansiär
Swedish Childhood Cancer Foundation
Merknad

Both last authors contributed equally.

Tilgjengelig fra: 2016-02-26 Laget: 2016-02-26 Sist oppdatert: 2019-03-29bibliografisk kontrollert
Inngår i avhandling
1. Hodgkin Lymphoma in children, adolescents and young adults
Åpne denne publikasjonen i ny fane eller vindu >>Hodgkin Lymphoma in children, adolescents and young adults
2017 (engelsk)Doktoravhandling, med artikler (Annet vitenskapelig)
Abstract [en]

Hodgkin lymphoma (HL) is a heterogeneous condition varying from engaging one single lymph node site to a widespread condition. The prognosis with contemporary treatment is excellent for the vast majority. However, the treatment might cause severe late adverse effects in a proportion of the affected individuals.

We evaluated all children and adolescents diagnosed in Sweden and registered in the Swedish Childhood Cancer Register over a period of 25 years. The incidence has been stable and the overall survival (OS) is very good, comparable to the best results in the world. Approximately ten percent encountered a relapse, but even after relapse the chances of survival were good. During the study period there were no detectable changes in survival estimates. The use of radiotherapy has decreased.

Epstein Barr virus (EBV) and numbers of eosinophils, mast cells and macrophages in the tumors were investigated in 98 cases. Young children were more likely to express EBV. In patients with advanced disease the mast cell and macrophage counts were higher and they also had more affected laboratory parameters. Patients with Nodular Lymphocyte Predominant Hodgkin Lymphoma did not express EBV in the tumor, had significantly lower numbers of eosinophils, mast cells and macrophages and less affected laboratory parameters compared to classical HL.

Outcome and clinical presentation were investigated in a cohort of children, adolescents and young adults in Sweden and Denmark and treatment in pediatric and adult departments was compared. OS and event-free survival (EFS) did not differ between the three age groups nor between pediatric and adult treatment. However, the Danish pediatric patients had lower EFS, which corresponded to less use of radiotherapy. Adolescents and young adults shared similar characteristics, while children presented differently with less advanced disease and male preponderance.

Hospitalization rates and outpatient visits after end of treatment were evaluated to see whether the excess need of resources described in the literature is evenly distributed among the survivors or whether it is limited to a smaller group. Most of the patients had a low burden of health care use and the relapsing patients were the main drivers of the excess need.

sted, utgiver, år, opplag, sider
Uppsala: Acta Universitatis Upsaliensis, 2017. s. 67
Serie
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 1314
Emneord
Hodgkin, pediatric, adolescent, young adults, microenvironment, eosinophils, mast cells, macrophages, Sweden, late adverse effects
HSV kategori
Forskningsprogram
Pediatrik; Medicinsk vetenskap; Onkologi
Identifikatorer
urn:nbn:se:uu:diva-316796 (URN)978-91-554-9851-1 (ISBN)
Disputas
2017-05-05, Rosénsalen, Ingång 95/96, Akademiska sjukhuset, Uppsala, 09:00 (svensk)
Opponent
Veileder
Tilgjengelig fra: 2017-04-12 Laget: 2017-03-12 Sist oppdatert: 2017-04-21

Open Access i DiVA

fulltext(593 kB)270 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 593 kBChecksum SHA-512
d6870a4d778b835ef135d25c74c25e8f3fa769a55f2dda3a3d6a7feac51125f788e63932d59b003c2ec014da0979619f07bc51619eadee28a56f19f5457b2891
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Englund, AnnikaMolin, DanielEnblad, GunillaGlimelius, IngridLjungman, GustafAmini, Rose-Marie

Søk i DiVA

Av forfatter/redaktør
Englund, AnnikaMolin, DanielEnblad, GunillaGlimelius, IngridLjungman, GustafAmini, Rose-Marie
Av organisasjonen
I samme tidsskrift
European Journal of Haematology

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 270 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 675 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf